Delivery Order SPE2DB20D3103-SPE2DB22FP6B0
- Not listed
- This federal contract award, valued at $1,324.32, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HYDROMORPHONE 1 MG/ML VIALML, a pharmaceutical product, and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,395.05, is a Firm Fixed Price Delivery Order for the supply of HYDROMORPHONE 1 MG/ML CARPUJCTML, a pharmaceutical product. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,137.70, is for the supply of hydromorphone 1 mg/ml carpujctml. This contract does not have a set-aside designation, indicating it was competitively awarded. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
- This federal contract award, valued at $4,332.75, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of hydromorphone 2 mg/ml vials, a medication used for pain management. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This federal contract award, valued at $1,179.54, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566516237 HYDROMORPHONE 2 MG/ML VIAL/ML, with an ultimate completion date of November 22, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of HYDROMORPHONE 1 MG/ML VIALML, a pharmaceutical product, with a firm fixed price of $1,195.90 and a completion date of March 7, 2024. The contract is not designated as a set-aside and was awarded as a delivery order under a larger indefinite delivery contract (IDC) with a potential...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,391.98 firm fixed-price delivery order is for the supply of HYDROMORPHONE 1 MG/ML CARPUJCTML, a pharmaceutical product, with a completion date of January 3, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,007.76 firm fixed price delivery order is for hydromorphone hydrochloride extended-release 8 mg tablets, with a completion date of February 11, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award is for the delivery of 12mg hydromorphone hydrochloride extended-release tablets to the Defense Logistics Agency (DLA), an agency within the U.S. Department of Defense. The $10,039.59 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on May 12, 2025, with a completion date of May 13, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,260.85, is for the delivery of 0.5 mg/0.5 ml hydromorphone, a pain medication. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 10, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00,...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB22FP6B0Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of hydromorphone 1 mg/ml vials. The $1,171.11 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract does not have a set-aside designation, indicating open competition. The award supports the procurement of critical medical commodities, including specialty medications, generic drugs, and injectable treatments, across various therapeutic areas to serve the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 8/23/22 |